Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 7, 2025; 31(9): 100271
Published online Mar 7, 2025. doi: 10.3748/wjg.v31.i9.100271
Published online Mar 7, 2025. doi: 10.3748/wjg.v31.i9.100271
Figure 4 Panaxadiol alleviated weight loss, reduced the Disease Activity Index score, and prevented colon shortening in mice with dextran sulfate sodium-induced colitis.
A: Body weight changes; B: Disease Activity Index score; C: Colon length. Data are expressed as mean ± standard error of the mean (n = 8). aP < 0.05; DAI: Disease Activity Index; DSS: Dextran sulfate sodium; PD: Panaxadiol.
- Citation: Qin Y, Zhang RY, Zhang Y, Zhao YQ, Hao HF, Wang JP. Network pharmacology and in vivo study: Unraveling the therapeutic mechanisms of Panax ginseng in potentially treating ulcerative colitis. World J Gastroenterol 2025; 31(9): 100271
- URL: https://www.wjgnet.com/1007-9327/full/v31/i9/100271.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i9.100271